- Home
- LRMR vs KTF Comparison
LRMR vs KTF Comparison
Compare LRMR & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- KTF
- Stock Information
- Founded
- LRMR N/A
- KTF 1988
- Country
- LRMR United States
- KTF United States
- Employees
- LRMR N/A
- KTF N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- KTF Finance Companies
- Sector
- LRMR Health Care
- KTF Finance
- Exchange
- LRMR Nasdaq
- KTF Nasdaq
- Market Cap
- LRMR 309.8M
- KTF 337.7M
- IPO Year
- LRMR N/A
- KTF N/A
- Fundamental
- Price
- LRMR $3.96
- KTF $9.29
- Analyst Decision
- LRMR Strong Buy
- KTF
- Analyst Count
- LRMR 8
- KTF 0
- Target Price
- LRMR $17.88
- KTF N/A
- AVG Volume (30 Days)
- LRMR 1.3M
- KTF 103.3K
- Earning Date
- LRMR 10-29-2025
- KTF 01-01-0001
- Dividend Yield
- LRMR N/A
- KTF 3.54%
- EPS Growth
- LRMR N/A
- KTF N/A
- EPS
- LRMR N/A
- KTF 0.39
- Revenue
- LRMR N/A
- KTF N/A
- Revenue This Year
- LRMR N/A
- KTF N/A
- Revenue Next Year
- LRMR N/A
- KTF N/A
- P/E Ratio
- LRMR N/A
- KTF $23.10
- Revenue Growth
- LRMR N/A
- KTF N/A
- 52 Week Low
- LRMR $1.61
- KTF $7.40
- 52 Week High
- LRMR $9.50
- KTF $9.12
- Technical
- Relative Strength Index (RSI)
- LRMR 54.10
- KTF 81.37
- Support Level
- LRMR $3.78
- KTF $8.75
- Resistance Level
- LRMR $4.26
- KTF $8.85
- Average True Range (ATR)
- LRMR 0.27
- KTF 0.08
- MACD
- LRMR -0.00
- KTF 0.06
- Stochastic Oscillator
- LRMR 55.14
- KTF 95.65
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.